Vitamin E, Research references

January 1999

1. Ackerman Z et al. Neurological manifestations in celiac disease and vitamin E. J Clin Nutr 11; 5: 603-5, 1989.
2. Anderson TW et al. A double-blind trial of vitamin E in angina pectoris. Am J Clin Nutr 27:1174-8, 1974.
3. Adayeva Y et al. Vitamin E treatment in dystrophy of the macula lutea. Am J Ophthalmol 56:498, 1963.
4. Ayres S, Ihan R. Post-herpes Zoster neuralgia: Response to Vitamin E Therapy. Arch Dermatol 108:855-6, 1973.
5. Ayres S, Mihan R. Is vitamin E involved in the autoimmune mechanism? Cutis 21: 321-5, 1978.
6. Barboriak JJ et al. Vitamin E supplements and plasma high-density lipoprotein cholesterol. Am J Clin Pathol 77;3:371, 1982.
7. Bellizzi MC, Franklin MF, Duthie GG, et al. Vitamin E and coronary heart disease: The European paradox. Eur J Clin Nutr 48:822-31, 1994.
8. Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr 48: 612-619, 1988.
9. Bierenbaum M et al. Relationship between serum lipid peroxidation products in hypercholesterolemic subjects and vitamin E status. Biochem Int 28:57-66, 1992.
10. Blankenhorn G. Vitamin E: Clinical research from Europe. Nutr Dietary Consult June, 1988.
11. Bruce A et al. The effect of selenium and vitamin E on glutathione peroxidase levels and subjective symptoms in patients with arthrosis and rheumatoid arthritis, in Proc N Z Workshop on Trace Elements in N Z. Dunedin, U. of Otago, 92, 1981.
12. Block MT. Vitamin E in the treatment of diseases of the skin. Clin Med January pp. 31-4, 1953.
13. Burgess JF, Pritchard JE. Tocopherol (vitamin E) treatment of lupus erythematosus: Preliminary report. Arch Dermatol Syphilol 57: 953, 1948.
14. Burton GW, Ingold KU. Vitamin E as an in vitro and in vivo antioxidant. In: Diplock AT, Machoin LJ, Parker L, Pryor WA, eds. Vitamin E: Biochemistry and health implications. Ann NY Acad Sci 570: 7-22, 1989.
15. Carpenter KLH et al. Depletion of alpha-tocopherol in human atherosclerotic lesions. Free Rad Res 23:549- 58, 1995.
16. Cavarocchi NC et al. Superoxide generation during cardiopulmonary bypass: Is there a role for vitamin E? J Surg Res 40:519-27, 1986.
17. Chamiec T et al. Effects of antioxidant vitamins C and E on signal-averaged electrocardiogram and acute myocardial infarction. Am J Cardiol 77:237-41, 1996.
18. Chavance M. Nutrition, immunity, and illness in the elderly. New York: Pergamon Press. p 137-142, 1985.
19. Cheraskin E, Ringsdorf WM, Jr. Nutr Rep Int 2: 107-117, 1970.
20. Cloarec MJ et al. Alpha-tocopherol: Effect on plasma lipoproteins in hypercholesterolemic patients. Isr J Med Sci 23;8:869-72, 1987.
21. Cochrane T. Post-herpes Zoster neuralgia: Response to Vitamin E Therapy. Letter. Arch Dermatol 111:396, 1975.
22. Coghlan JG, Flitter WD, Clutton SM, et al. Lipid peroxidation and changes in vitamin E levels during coronary artery bypass grafting. J Thorac Cardiovasc Surg 106;2:268-74, 1993.
23. Comstock GW et al. Serum concentrations of alpha-tocopherol, beta-carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 56: 323-5, 1997.
24. Creighton MO, Trevitchick JR. Cortical cataract formation prevented by vitamin E and glutathione. Exp Eye Res 29:6:689-93, 1979.
25. Creighton MO et al. Modelling cortical cataractogenesis: V. Steroid cataracts induced by Solu-medrol partially prevented by vitamin E in vitro. Exp Eye Res 37:1:65-76, 1983.
26. Creter D et al. Effect of vitamin E on platelet aggregation in diabetic retinopathy. Acta Hematol 62:74, 1979.
27. DeMaio SJ et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty PTCA. J Am Coll Nutr 11;1:68-73, 1992.
28. Dieber-Rotheneder M et al. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 32:1325- 32, 1991.
29. DiMascio P, Murphy M, Sies H. Antioxidant and defense systems. The role of carotenoids, tocopherols and thiols. Am J Clin Nutr 53: S194-200, 1991.
30. Dimitrov NV et al. Plasma tocopherol concentrations in response to supplements vitamin E. Am J Clin Nutr 1991; 53: 723-729, 1991.
31. Diplock AT, Machlin LJ, Packer L et al, eds. Daily vitamin E consumption and reported cardiovascular findings. New York: Ann NY Acad Sci. 1989: p 1-535, 1989.
32. Eldred GE. Vitamins A and E in RPE lipofuscin formation and implications for age-related macular degeneration. Prog Clin Biol Res 314:113-29, 1989.
33. Esterbauer H, Dieber-Rotheneder M, Striegl G et al. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 1991; 53: 314S-321S.
34. Fahn S. A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson’s disease. Ann Neurol 32:S128-32, 1992; Fahn S. An open trial of high-dosage antioxidants in early Parkinson’s disease. Am J Clin Nutr 53:380S-1S, 1991.
35. Factor SA, Sanchez-Ramos JR, Weiner WJ. Vitamin E therapy in Parkinson’s disease. Adv Neurol 53:457-61, 1990.
36. Ferreira R et al. Antioxidant action of vitamins A and E in patients submitted to coronary bypass surgery. Vasc Surg 25:191-5, 1991.
37. Fink M, Fink J. Treatment of herpes simplex by alpha-tocopherol (Vitamin E). Br Dent J 148:246, 1980.
38. Fong JSC. Alpha-tocopherol. Its inhibition on human platelet aggregation. Experientia 32: 639-641, 1976.
39. Gaby WK et al. Vitamin intake and health: A scientific review. New York: Marcel Dekker. 1991: p 71-101.
40. Gey KF. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J of Clin Nutr 53 (suppl.1); 326S-34S, 1991.
41. Giani E et al. Heated fat; vitamin E and vascular eicosanoids. Lipids 20: 439-448, 1985.
42. Haenszel W, Correa P, Lopez A et al. Serum micronutrient levels in relation to gastric pathology. Int J Cancer 36: 43-48, 1985.
43. Hayes KC. Retinal degeneration in monkeys induced by deficiencies of vitamin E or A. Invest Ophthalmol Vis Sci 13:7:499-510, 1974.
44. Hennig B et al. Protective effects of vitamin E in age-related endothelial cell injury. Int J Vitam Nutr Res 59:273-9, 1989.
45. Herbaczynska-Cedro K, Klosiewicz-Wasek B, Cedro K, et al. Supplementation with vitamins C and E suppresses leukocyte oxygen free radical production in patients with myocardial infarction. Eur Heart J 16: 1044-9, 1995.
46. Hermann WJ et al. The effect of tocopherol on high-density lipoprotein cholesterol: A clinical observation. Am J Clin Pathol 72:848-52, 1979.
47. Honkanen V et al. Vitamins A and E, retinol binding protein and zinc in rheumatoid arthritis. Clin Exp Rheumatol 7: 465-9, 1989.
48. Honkanen VEA et al. Serum cholesterol and vitamins A and E in juvenile chronic arthritis. Clin Exp Rheumatol 8: 187-91, 1990.
49. Horwitt MK. Supplementation with vitamin E. Am J Clin Nutr 47: 1088-1089, 1988.
50. Hu JJ et al. Effects of dietary supplementation of alpha-tocopherol on plasma glutathione and DNA repair activities. Canc Epidemiol Biomark Preven 5; (4): 263-70, 1996.
51. Jacques PF. Chylack antioxidant status in persons with and without senile cataract. Arch Ophthalmol 106: 337-340, 1988.
52. Jain SK, McVie R, Jaramillo JJ, et al. The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids 31:S87-90, 1996.
53. James S et al. Effekter av selenvitamin E-behandling till kvinnor med lång variga arbetsrelaterade nack-och skuldersmärtor. En dubbelblindstudie. Läkaresällskapets Riksstämma, 1985.
54. Jandak J et al. Reduction of platelet adhesiveness by vitamin E supplementation in humans. Thrombosis Res 49:393-404, 1988.
55. Jandak J et al. Alpha tocopherol, an effective inhibitor of platelet adhesion. Blood 73:141-9, 1989.
56. Jialal I, Grundy SM. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 33;6:899-906, 1992.
57. Jialal L, Fuller CJ, Hunt BA. The effect of alpha-tocopherol supplementation on LDL oxidation. Arterioscler Thromb Vasc Biol 15:190-8, 1995.
58. Juhlin L et al. Blood glutathione-peroxidase levels in skin diseases: Effect of selenium and vitamin E treatment. Acta Derm Venereal (Stockh) 62; 3: 211-4, 1982.
59. Knekt P et al. Serum vitamin E level and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol 127: 28-41, 1988.
60. Kneckt P. Serum vitamin E level and risk of female cancers. Int J Epidem 17: 281-286, 1988.
61. Knekt P, Aromaa A, Maatela J et al. Vitamin E and cancer prevention. Am J Clin Nutr 53: 283S-286S, 1991.
62. Kok FJ, de Bruijn AM, Vermeeren R et al. Serum selenium, vitamin antioxidants, and cardiovascular mortality. N Eng J Med 316: 1416, 1987.
63. London R.S. et al. Endocrine Parameters and Alpha-Tocopherol Therapy of Patients with Mammary Dysplasia, Cancer Res 41; 3811-3, 1981.
64. London RS, et al. The Effect of Alpha-tochopherol on Premenstrual Symptomatology: A Double-blind Study. II Endocrine Correlates, J Am Col Nutr 3 : 351-6, 1984.
65. Losonczy, KG, Harris, TB, Havlik, RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons. The established populations for epidemiologic studies of the elderly. Am J Clin Nutr 64: 190-196, 1996.
66. Machlin LJ. Use and safe of elevated dosages of vitamin E in adults. Int J Vitam Nutr Res Suppl 30: 56-68, 1989.
67. Machtey I, Ouaknine, L. Tocopherol in osteoarthritis: A controlled pilot study. J Am Geriatr Soc 26: 328-30, 1978.
68. Mauro A, Orsi L, Mortara P, et al. Cerebellar syndrome in adult celiac disease with vitamin E deficiency. Acta Neurol Scand 84; 2:167-70, 1990.
69. Menkes MS, Comstock GW, Vuilleumier JP et al. Serum beta carotene vitamins A and E, selenium, and the risk of lung cancer. N Eng J Med 315: 1250-1254, 1986.
70. Meydani M et al. Muscle uptake of vitamin E and its association with muscle fiber type. Nutr Biochem 8: 74-78, 1997.
71. Mezes M, Bartosiewicz G. Investigations on vitamin E and lipid peroxide status in rheumatic diseases. Clin Rheumatol 2; 3: 259-63, 1983.
72. Mezzetti A, Lapenna D, Pierdomenico SD, et al. Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and nonsmokers. Atherosclerosis 112: 91-9, 1995.
73. Miwa K, Miyagi Y, Igawa A, et al. Vitamin E deficiency in variant angina. Circulation 94;1:14-18, 1996.
74. Miyamoto H, Araya Y, Ito M et al. Serum selenium and vitamin E. concentrations in families of lung cancer patients. Cancer 60: 1159-1162, 1987.
75. Muckle T, Hazir D. Variation in human blood high-density lipoprotein response to oral vitamin E megadosage. Am J Clin Pathol 91: 165-71, 1989.
76. Munthe E, Aaseth J. Treatment of Rheumatoid Arthritis with Selenium and Vitamin E. Scan J of Rheumatol 53; (suppl.): 103, 1984.
77. Nead DE. Effective vitamin E treatment for ulcerative herpetic lesions. Dent Survey 52; (7):50-1, 1976.
78. Niki E, Yamamoto Y, Komuro E et al. Membrane damage due to lipid oxidation. Am J Clin Nutr  53: S201-205, 1991.
79. Novelli GP et al. Vitamin E protects human skeletal muscle from damage during surgical ischemia-reperfusion. Am J Surg March 173: 206-9, 1997.
80. Odeleye OE, Watson RR. The potential role of vitamin E in the Treatment of immunologic abnormalities during Acquired Immune Deficiency Syndrome. Prog Food Nutr Sci 15; (1-2):1-19, 1991.
81. Pacht ER, Kaseki H, Mohammed JR et al. Deficiency of vitamin E in the alveolar fluid of cigarette smokers. J Clin Invest 77: 789-798, 1986.
82. Paolisso G et al. Cronic Intake of Pharmacological Doses of Vitamin E Might be Useful in the Therapy of Elderly Patients with Coronary Heart Disease. Am J Clin Nutr 61: 848-52, 1995.
83. Pascoe GA, Fariss MW, Olafsdottir K et al. A role of vitamin E in protection against cell injury. Maintenance of intracellular glutathione precursors and biosynthesis. Eur J Biochem 166: 241-247, 1987.
84. Prasad JS. Effect of vitamin E supplementation on leukocyte function. Am J Clin Nutr 33: 606-608, 1980.
85. Princen H, van Poppel G, Vogelezang C, et al. Supplementation with vitamin E but not beta carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: Effect of cigarette smoking. Arter Throm 12: 554-62, 1992.
86. Princen HM et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 15: 325-33, 1995.
87. Pryor WA. Can vitamin E protect humans against the pathological effects of ozone in smog? Am J Clin Nutr 53: 702-722, 1991.
88. RabinovitchR et al. Neuromuscular disorders amenable to wheat germ oil therapy. J Neurol Neurosurg Psychiatry 14: 95-100, 1951.
89. Reddy ACP, Lokesh BR. Dietary unsaturated fatty acids, vitamin E, curcumin and eugenol
90. alter serum and liver lipid peroxidation in rats. Nutr Res 14: 1423-37, 1994.
91. Regnström J, Nilsson J, Moldeus P, et al. Inverse relation between the concentration of low-density- lipoprotein vitamin E and severity of coronary artery disease. Am J Clin Nutr 63: 377-85, 1996.
92. Riemersma RA, Wood DA, MacIntyre CCH, et al. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 337: 1-5, 1991.
93. Riemersma RA, Wood DA, MacIntyre CCA et al. Low plasma vitamins E and C increased risk of angina in Scottish men. In: Diplock AT, Machlin LJ, Packer L et al, eds. Vitamin E: Biochemistry and health implications, vol. 570. New York: Ann NY Acad Sci. p 291-295, 1989.
94. Robertson JM, Donner AP, Trevithick JR. Vitamin E: Biochemistry and health implications, vol. 570. New York: Ann NY Acad Sci. p 372-382, 1989.
95. Robertson JM, Donner AP, Trevithick JR. Vitamin E intake and risk of cataracts in humans. Ann NY Acad Sci 570: 372-378, 1989.
96. Robertson JM et al. Vitamin E intake and risk of cataracts in humans. Ann N Y Acad Sci 570: 372-82, 1989.
97. Robison WG Jr et al. Vitamin E deficiency and the retina: Photoreceptor and pigment epithelial changes. Invest Ophthalmol Vis Sci 18:7:683-90, 1979.
98. Romeo G. The therapeutic effect of vitamins A and E in neurosensory hearing loss. Acta Vitaminol Enzymol 7 Suppl:85-92, 1985.
99. Ross WM et al. Modelling cortical cataractogenesis: III. In vivo effects of vitamin E on cataractogenesis in diabetic rats. Can J Ophthalmol 17:2: 61-6, 1982.
100. Ross WM et al. Radiation cataract formation diminished by vitamin E in rat lenses in vitro. Exp Eye Res 36:5: 645-53, 1983.
101. Ross WM, Creighton MO, Trevithick JR. Radiation cataractogenesis induced by neutron or gamma irradiation in the rat lens is reduced by vitamin E. Scan Micros 4: 641-50, 1990.
102. Rouhiainen P, Rouhiainen H, Salonen J, et al. Association between low plasma vitamin E concentration and progression of early cortical lens opacities. Am J Epidemiol 144: 5: 496-500, 1996.
103. Sahyoun NR et al. Carotenoids, vitamins C and E, and mortality in an elderly population. Am J Epidemiol 144:5:501-11, 1996.
104. Saito T. The preventive effect of vitamin E on gallstone formation. (1). A study of biliary cholesterol and bile acids in vitamin E-deficient hamsters. Arch Jpn Chir 56; 3: 247-61, 1987.
105. Salonen JT, Salonen R, Lappetelainen R et al. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E. matched case-control analysis of prospective data. Br Med J 290: 417-420, 1985.
106. Salonen JT et al. Increased Risk of Non-Insulin Diabetes Mellitus at Low Plasma Vitamin E Concentrations: A Four-Year Follw-up Study in Men. Br Med J 311: 1124-27, 1995.
107. Schwartz ER. The modulation of osteoarthritic development by vitamins C and E. Int J Vitam Nutr Res Suppl. 26: 141-6, 1984.
108. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 272:1413-20, 1994.
109. Simon E et al. Plasma and erythrocyte vitamin E content in asymptomatic hypercholesterolemic subjects. Clin Chem 43:2:285-9, 1997.
110. Simons LA, Von Konigsmark M, Balasubramaniam S. What dose of vitamin E is required to reduce susceptibility of LDL to oxidation? Aust N Z J Med 26;4:496-503, 1996.
111. Sklodowska M, Wasowicz W, Gromnadzinska J, et al. Selenium and vitamin E concentrations in plasma and erythrocytes of angina pectoris patients. Trace Elem Med 8:113-17, 1991.
112. Sklodowska M et al. Vitamin E, thiobarbituric acid reactive substance concentrations and superoxide dismutase activity in the blood of children with juvenile rheumatoid arthritis. Clin Exp Rheumatol 14: 433-9, 1996.
113. Sokol RJ. Vitamin E. In: Ziegler EE, Filer LJ Jr, eds. Present knowledge in nutrition. 7th edn. Washington DC: International Life Sciences Press. p 130-136, 1996.
114. Stampfer M, Hennekens C, Manson J, et al. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med 328:1444-9, 1993.
115. Starasoler S, Haber GS. Use of vitamin E oil in primary herpes gingivostomatitis in an adult. N Y State Dent J 44; (9):382-3, 1978.
116. Steinberg CL. Vitamin E and collagen in the rheumatic diseases. Ann N Y Acad Sci 52:380-9, 1949.
117. Steiner M. Effect of alpha-tocopherol administration on platelet function in man. Thromb Haemostas 49: 73-77, 1983.
118. Steiner M. Influence of vitamin E on platelet function in humans. J Am Coll Nutr 10;5:466-73, 1991.
119. Steiner M, Glantz M, Lekos A. Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. Am J Clin Nutr 62; suppl:1381S-4S, 1995.
120. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study CHAOS. Lancet 347:781-6, 1996.
121. Stone WL et al. Effects of dietary selenium and vitamin E on plasma lipoprotein cholesterol levels in male rats. Ann Nutr Metab 30: 94-103, 1986.
122. Street DA et al. Serum antioxidants and myocardial infarction: Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 90; 3:1154-61, 1994.
123. Suzukawa M, Ishikawa T, Yoshida H, Tokorozawa N. Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr 14:1:46-52, 1995.
124. Suzuki T, Kawase T, Harada T. Clinical study of vitamin E status in patients with chronic liver diseases. Nippon Shokakibyo Gakkai Zasshi 88; 4:1066-73, 1991.
125. Sword J, Pope A, Hoekstra W. Endotoxin and lipid peroxidation in vitro in selenium and vitamin E deficient and adequate rat tissue. J Nutr 121: 251-257, 1991.
126. Sword J, Pope A, Hoekstra W. Endotoxin and lipid peroxidation in vitro in selenium and vitamin E deficient and adequate rat tissue. J Nutr 121: 258-264, 1991.
127. Takamatsu S, Takamatsu M, Satoh K, et al. Effects on health of dietary supplementation with 100 mg d-alpha tocopheryl acetate, daily for 6 years. J Int Med Res 23:342-57, 1995.
128. Tang AM et al. Association between Serum Vitamin A and E levels and HIV-1 disease progression. AIDS 11:613-20, 1997.
129. Taylor A. Associations between nutrition and cataract. Nutr Rev 47: 225-234, 1989.
130. Tolonen M, Markku H, Sarna S. Vitamin E and selenium supplementation in geriatric patients A double-blind preliminary clinical trial. Biol Trace Elem Res 7: 161-168, 1985.
131. Torun M et al. Serum levels of vitamin E in relation to cardiovascular diseases. J Clin Pharm Therap 20:335-40, 1995.
132. Van Den Berg JJ, Roelofsen B, OpdenKamp JAF et al. Vitamin E: Biochemistry and health implications, vol. 570. New York: Ann NY Acad Sci. p 527-529, 1989.
133. Veris Research Summary. The role of antioxidants in prevention of coronary heart disease. p 1-16, Nov. 1996.
134. Verlangieri AJ, Bush MJ. Effects of d-a-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 11;2:131-8, 1992.
135. Vitale S et al. Plasma vitamin C, E and beta carotene levels and risk of cataract. Invest Ophthalmol Vis Sci 32:723, 1991.
136. Wald NJ, Boreham J, Hayward JL et al. Plasma retinol beta carotene and vitamin E levels in relation to future risk of breast cancer. Br J Cancer 49: 321-324, 1984.
137. Wang Y, Watson RR. Potential Therapeutics of Vitamin E (Tocopherol) in AIDS and HIV, Drugs 48:327-38, 1994.
138. Weisburger J. Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants and carotenoids. Am J Clin Nutr 53: S226-237, 1991.
139. Welsh AL. Lupus erythematosus: Treatment by combined use of massive amounts of pantothenic acid and vitamin E. Arch Dermatol Syphilol 70: 181-98, 1954.
140. White G. Vitamin E inhibition of platelet prostaglandin biosynthesis. Fed Proc 36: 350, 1977.
141. Yau TM, Weisel RD, Mickle DA, et al. Vitamin E for coronary bypass operations. A prospective, double-blind, randomized trial. J Thorac Cardiovasc Surg 108; 2: 302-10, 1994.
142. Örndahl G et al. Myotonic dystrophy treated with selenium and vitamin E. Acta Med Scand 219: 409-44, 1986.


Joseph E. Pizzorno Jr., Michael T. Murrey & Melvyn R. Werbach.